Total ApoE and ApoE4 isoform assays in an Alzheimer's disease case-control study by targeted mass spectrometry (n = 669): A pilot assay for methionine-containing proteotypic peptides

Molecular and Cellular Proteomics

Volumn 11, Issue 11, 2012, Pages 1389-1403

  Simon, Romain ^a   Girod, Marion ^a   Fonbonne, Catherine ^a   Salvador, Arnaud ^a   Clément, Yohann ^a   Lantéri, Pierre ^a   Amouyel, Philippe ^b,c,d   Lambert, Jean Charles ^a,b,c,d   Lemoine, Jérôme ^a  

^a Institut des Sciences Analytiques   (France)

^b INSERM   (France)

^c INSTITUT PASTEUR DE LILLE   (France)

^d UNIV LILLE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; APOLIPOPROTEIN E4; ISOPROTEIN; METHIONINE; PEPTIDE;

ALLELE; ALZHEIMER DISEASE; AMINO ACID SEQUENCE; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DIAGNOSTIC VALUE; ENZYME IMMUNOASSAY; FEMALE; GENETIC VARIABILITY; HETEROZYGOTE; HUMAN; LIQUID CHROMATOGRAPHY; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETRY; OXIDATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION;

ALZHEIMER DISEASE; AMINO ACID SEQUENCE; APOLIPOPROTEIN E4; CALIBRATION; CASE-CONTROL STUDIES; COHORT STUDIES; HUMANS; HYDROLYSIS; MASS SPECTROMETRY; METHIONINE; MOLECULAR SEQUENCE DATA; OXIDATION-REDUCTION; PEPTIDES; PILOT PROJECTS; PRINCIPAL COMPONENT ANALYSIS; PROTEIN ISOFORMS; REPRODUCIBILITY OF RESULTS; TIME FACTORS;

EID: 84869217993     PISSN: 15359476     EISSN: 15359484     Source Type: Journal    
DOI: 10.1074/mcp.M112.018861     Document Type: Article

References (96)

1. Hatters, D. M., Peters-Libeu, C. A., and Weisgraber, K. H. (2006) Apolipoprotein E structure: insights into function. Trends Biochem. Sci. 31, 445-454 (Pubitemid 44108662)
2. Verghese, P. B., Castellano, J. M., and Holtzman, D. M. (2011) Apolipoprotein E in Alzheimer's disease and other neurological disorders. Lancet Neurol. 10, 241-252
3. Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., Roses, A. D., Haines, J. L., and Pericak-Vance, M. A. (1993) Gene dose of apolipoprotein-E type-4 allele and the risk of Alzheimers-disease in late-onset families. Science 261, 921-923 (Pubitemid 23275809)
4. Weisgraber, K. H., and Mahley, R. W. (1996) Human apolipoprotein E: The Alzheimer's disease connection. FASEB J. 10, 1485-1494 (Pubitemid 26384445)
5. Taddei, K., Clarnette, R., Gandy, S. E., and Martins, R. N. (1997) Increased plasma apolipoprotein E (apoE) levels in Alzheimer's disease. Neurosci. Lett. 223, 29-32 (Pubitemid 27093012)
6. Gupta, V. B., Laws, S. M., Villemagne, V. L., Ames, D., Bush, A. I., Ellis, K. A., Lui, J. K., Masters, C., Rowe, C. C., Szoeke, C., Taddei, K., and Martins, R. N. (2011) Plasma apolipoprotein E and Alzheimer disease risk The AIBL study of aging. Neurology 76, 1091-1098
7. Lehtimaki, T., Pirttila, T., Mehta, P. D., Wisniewski, H. M., Frey, H., and Nikkari, T. (1995) Apolipoprotein-E (Apoe) polymorphism and its influence on Apoe concentrations in the cerebrospinal-fluid in Finnish patients with Alzheimers-disease. Human Gen. 95, 39-42
8. Scacchi, R., Gambina, G., Ruggeri, M., Martini, M. C., Ferrari, G., Silvestri, M., Schiavon, R., and Corbo, R. M. (1999) Plasma levels of apolipoprotein E and genetic markers in elderly patients with Alzheimer's disease. Neurosci. Lett. 259, 33-36 (Pubitemid 29051535)
9. Slooter, A. J. C., de Knijff, P., Hofman, A., Cruts, M., Breteler, M. M. B., Van Broeckhoven, C., Havekes, L. M., and van Duijn, C. M. (1998) Serum apolipoprotein E level is not increased in Alzheimer's disease: the Rotterdam study. Neurosci. Lett. 248, 21-24 (Pubitemid 28267093)
10. Solfrizzi, V., Panza, F., Colacicco, A. M., D'Introno, A., Basile, A. M., Capurso, C., Sabba, M., Mascolo, E., and Capurso, A. (2003) Apolipoprotein E (APOE) polymorphism influences serum APOE levels in Alzheimer's disease patients and centenarians. Int. Psychogeriatrics 15, 40-41
11. Addona, T. A., Shi, X., Keshishian, H., Mani, D. R., Burgess, M., Gillette, M. A., Clauser, K. R., Shen, D., Lewis, G. D., Farrell, L. A., Fifer, M. A., Sabatine, M. S., Gerszten, R. E., and Carr, S. A. (2011) A pipeline that integrates the discovery and verification of plasma protein biomarkers reveals candidate markers for cardiovascular disease. Nat. Biotechnol. 29, 635-643
12. Anderson, L., and Hunter, C. L. (2006) Quantitative mass spectrometric multiple reaction monitoring assays for major plasma proteins. Mol. Cell. Proteomics 5, 573-588
13. Domon, B., and Aebersold, R. (2010) Options and considerations when selecting a quantitative proteomics strategy. Nat. Biotechnol. 28, 710-721
14. Huettenhain, R., Malmstroem, J., Picotti, P., and Aebersold, R. (2009) Perspectives of targeted mass spectrometry for protein biomarker verification. Curr. Opinion Chem. Biol. 13, 518-525
15. Lin, S., Shaler, T. A., and Becker, C. H. (2006) Quantification of intermediate-abundance proteins in serum by multiple reaction monitoring mass spectrometry in a single-quadrupole ion trap. Anal. Chem. 78, 5762-5767 (Pubitemid 44265037)
16. Schiess, R., Wollscheid, B., and Aebersold, R. (2009) Targeted proteomic strategy for clinical biomarker discovery. Mol. Oncol. 3, 33-44
17. Surinova, S., Schiess, R., Huettenhain, R., Cerciello, F., Wollscheid, B., and Aebersold, R. (2011) On the development of plasma protein biomarkers. J. Proteome Res. 10, 5-16
18. Makawita, S., and Diamandis, E. P. (2010) The bottleneck in the cancer biomarker pipeline and protein quantification through mass spectrometry-based approaches: current strategies for candidate verification. Clin. Chem. 56, 212-222
19. Rifai, N., Gillette, M. A., and Carr, S. A. (2006) Protein biomarker discovery and validation: the long and uncertain path to clinical utility. Nat. Biotechnol. 24, 971-983 (Pubitemid 44215392)
20. Whiteaker, J. R., Lin, C., Kennedy, J., Hou, L., Trute, M., Sokal, I., Yan, P., Schoenherr, R. M., Zhao, L., Voytovich, U. J., Kelly Spratt, K. S., Krasnoselsky, A., Gafken, P. R., Hogan, J. M., Jones, L. A., Wang, P., Amon, L., Chodosh, L. A., Nelson, P. S., McIntosh, M. W., Kemp, C. J., and Paulovich, A. G. (2011) A targeted proteomics-based pipeline for verification of biomarkers in plasma. Nat. Biotechnol. 29, 625-U108
21. Carr, S. A., and Anderson, L. (2008) Protein quantitation through targeted mass spectrometry: the way out of biomarker purgatory? Clin. Chem. 54, 1749-1752
22. Paulovich, A. G., Whiteaker, J. R., Hoofnagle, A. N., and Wang, P. (2008) The interface between biomarker discovery and clinical validation: The tar pit of the protein biomarker pipeline. Proteomics Clin. Appl. 2, 1386-1402
23. Hoofnagle, A. N., Becker, J. O., Wener, M. H., and Heinecke, J. W. (2008) Quantification of thyroglobulin, a low-abundance serum protein, by immunoaffinity peptide enrichment and tandem mass spectrometry. Clin. Chem. 54, 1796-1804
24. Keshishian, H., Addona, T., Burgess, M., Kuhn, E., and Carr, S. A. (2007) Quantitative, multiplexed assays for low abundance proteins in plasma by targeted mass spectrometry and stable isotope dilution. Mol. Cell. Proteomics 6, 2212-2229
25. Fortin, T., Salvador, A., Charrier, J. P., Lenz, C., Lacoux, X., Morla, A., Choquet-Kastylevsky, G., and Lemoine, J. (2009) Clinical quantitation of prostate-specific antigen biomarker in the low nanogram/milliliter range by conventional bore liquid chromatography-tandem mass spectrometry (multiple reaction monitoring) coupling and correlation with ELISA tests. Mol. Cell. Proteomics 8, 1006-1015
26. Yang, Y., Qiang, X., Owsiany, K., Zhang, S., Thannhauser, T. W., and Li, L. (2011) Evaluation of different multidimensional LC-MS/MS pipelines for isobaric tags for relative and absolute quantitation (iTRAQ)-based proteomic analysis of potato tubers in response to cold storage. J. Proteome Res. 10, 4647-4660
27. Kuhn, E., Addona, T., Keshishian, H., Burgess, M., Mani, D. R., Lee, R. T., Sabatine, M. S., Gerszten, R. E., and Carr, S. A. (2009) Developing multiplexed assays for troponin I and interleukin-33 in plasma by peptide immunoaffinity enrichment and targeted mass spectrometry. Clin. Chem. 55, 1108-1117
28. Prakash, A., Rezai, T., Krastins, B., Sarracino, D., Athanas, M., Russo, P., Ross, M. M., Zhang, H., Tian, Y., Kulasingam, V., Drabovich, A. P., Smith, C., Batruch, I., Liotta, L., Petricoin, E., Diamandis, E. P., Chan, D. W., and Lopez, M. F. (2010) Platform for establishing inter laboratory reproducibility of selected reaction monitoring-based mass spectrometry peptide assays. J. Proteome Res. 9, 6678-6688
29. Addona, T. A., Abbatiello, S. E., Schilling, B., Skates, S. J., Mani, D. R., Bunk, D. M., Spiegelman, C. H., Zimmerman, L. J., Ham, A. J. L., Keshishian, H., Hall, S. C., Allen, S., Blackman, R. K., Borchers, C. H., Buck, C., Cardasis, H. L., Cusack, M. P., Dodder, N. G., Gibson, B. W., Held, J. M., Hiltke, T., Jackson, A., Johansen, E. B., Kinsinger, C. R., Li, J., Mesri, M., Neubert, T. A., Niles, R. K., Pulsipher, T. C., Ransohoff, D., Rodriguez, H., Rudnick, P. A., Smith, D., Tabb, D. L., Tegeler, T. J., Variyath, A. M., Vega-Montoto, L. J., Wahlander, A., Waldemarson, S., Wang, M., Whiteaker, J. R., Zhao, L., Anderson, N. L., Fisher, S. J., Liebler, D. C., Paulovich, A. G., Regnier, F. E., Tempst, P., and Carr, S. A. (2009) Multi-site assessment of the precision and reproducibility of multiple reaction monitoring-based measurements of proteins in plasma. Nat. Biotechnol. 27, 633-U85
30. Keshishian, H., Addona, T., Burgess, M., Mani, D. R., Shi, X., Kuhn, E., Sabatine, M. S., Gerszten, R. E., and Carr, S. A. (2009) Quantification of cardiovascular biomarkers in patient plasma by targeted mass spectrometry and stable isotope dilution. Mol. Cell. Proteomics 8, 2339-2349
31. Kuhn, E., Whiteaker, J. R., Mani, D. R., Jackson, A. M., Zhao, L., Pope, M. E., Smith, D., Rivera, K. D., Anderson, N. L., Skates, S. J., Pearson, T. W., Paulovich, A. G., and Carr, S. A. (2012) Inter-laboratory evaluation of automated, multiplexed peptide immunoaffinity enrichment coupled to multiple reaction monitoring mass spectrometry for quantifying proteins in plasma. Mol. Cell. Proteomics 11, M111.013854
32. Paulovich, A. G., Billheimer, D., Ham, A. J. L., Vega-Montoto, L., Rudnick, P. A., Tabb, D. L., Wang, P., Blackman, R. K., Bunk, D. M., Cardasis, H. L., Clauser, K. R., Kinsinger, C. R., Schilling, B., Tegeler, T. J., Variyath, A. M., Wang, M., Whiteaker, J. R., Zimmerman, L. J., Fenyo, D., Carr, S. A., Fisher, S. J., Gibson, B. W., Mesri, M., Neubert, T. A., Regnier, F. E., Rodriguez, H., Spiegelman, C., Stein, S. E., Tempst, P., and Liebler, D. C. (2010) Interlaboratory study characterizing a yeast performance standard for benchmarking LC-MS platform performance. Mol. Cell. Proteomics 9, 242-254
33. Selevsek, N., Matondo, M., Sanchez, Carbayo, M., Aebersold, R., and Domon, B. (2011) Systematic quantification of peptides/proteins in urine using selected reaction monitoring. Proteomics 11, 1135-1147
34. Gallien, S., Duriez, E., and Domon, B. (2011) Selected reaction monitoring applied to proteomics. J. Mass Spectrom. 46, 298-312
35. Lange, V., Picotti, P., Domon, B., and Aebersold, R. (2008) Selected reaction monitoring for quantitative proteomics: a tutorial. Mol. Syst. Biol. 4, article number 222
36. Pan, S., Aebersold, R., Chen, R., Rush, J., Goodlett, D. R., McIntosh, M. W., Zhang, J., and Brentnall, T. A. (2009) Mass spectrometry based targeted protein quantification: methods and applications. J. Proteome Res. 8, 787-797
37. Shacter, E. (2000) Quantification and significance of protein oxidation in biological samples. Drug Metab. Rev. 32, 307-326
38. Vogt, W. (1995) Oxidation of methionyl residues in proteins - tools, targets, and reversal. Free Radical Biol. Med. 18, 93-105
39. Gerber, S. A., Rush, J., Stemman, O., Kirschner, M. W., and Gygi, S. P. (2003) Absolute quantification of proteins and phosphoproteins from cell lysates by tandem MS. Proc. Natl. Acad. Sci. U. S. A. 100, 6940-6945 (Pubitemid 36706372)
40. Huillet, C., Adrait, A., Lebert, D., Picard, G., Trauchessec, M., Louwagie, M., Dupuis, A., Hittinger, L., Ghaleh, B., Le Corvoisier, P., Jaquinod, M., Garin, J., Bruley, C., and Brun, V. (2012) Accurate quantification of cardiovascular biomarkers in serum using Protein Standard Absolute Quantification (PSAQ™) and selected reaction monitoring. Mol. Cell. Proteomics 11, M111.008235
41. Kuzyk, M. A., Smith, D., Yang, J., Cross, T. J., Jackson, A. M., Hardie, D. B., Anderson, N. L., and Borchers, C. H. (2009) Multiple reaction monitoring-based, multiplexed, absolute quantitation of 45 proteins in human plasma. Mol. Cell. Proteomics 8, 1860-1877
42. Proc, J. L., Kuzyk, M. A., Hardie, D. B., Yang, J., Smith, D. S., Jackson, A. M., Parker, C. E., and Borchers, C. H. (2010) A quantitative study of the effects of chaotropic agents, surfactants, and solvents on the digestion efficiency of human plasma proteins by trypsin. J. Proteome Res. 9, 5422-5437
43. Shchepin, R., Moeller, M. N., Kim, H. Y. H., Hatch, D. M., Bartesaghi, S., Kalyanaraman, B., Radi, R., and Porter, N. A. (2010) Tyrosine-lipid peroxide adducts from radical termination: para coupling and intramolecular diels-alder cyclization. J. Am. Chem. Soc. 132, 17490-17500
44. Fukumoto, H., Ingelsson, M., Garevik, N., Wahlund, L. O., Nukina, N., Yaguchi, Y., Shibata, M., Hyman, B. T., Rebeck, G. W., and Irizarry, M. C. (2003) APOE epsilon 3/epsilon 4 heterozygotes have an elevated proportion of apolipoprotein E4 in cerebrospinal fluid relative to plasma, independent of Alzheimer's disease diagnosis. Exp. Neurol. 183, 249-253 (Pubitemid 37075875)
45. Wildsmith, K. R., Han, B., and Bateman, R. J. (2009) Method for the simultaneous quantitation of apolipoprotein E isoforms using tandem mass spectrometry. Anal. Biochem. 395, 116-118
46. Agger, S. A., Marney, L. C., and Hoofnagle, A. N. (2010) Simultaneous quantification of apolipoprotein A-I and apolipoprotein B by liquid-chromatography-multiple-reaction-monitoring mass spectrometry. Clin. Chem. 56, 1804-1813
47. Ghesquiere, B., Jonckheere, V., Colaert, N., Van Durme, J., Timmerman, E., Goethals, M., Schymkowitz, J., Rousseau, F., Vandekerckhove, J., and Gevaert, K. (2011) Redox proteomics of protein-bound methionine oxidation. Mol. Cell. Proteomics 10, M110.006866
48. Gevaert, K., Pinxteren, J., Demol, H., Hugelier, K., Staes, A., Van Damme, J., Martens, L., and Vandekerckhove, J. (2006) Four stage liquid chromatographic selection of methionyl peptides for peptide-centric proteome analysis: The proteome of human multipotent adult progenitor cells. J. Proteome Res. 5, 1415-1428 (Pubitemid 43865811)
49. Gevaert, K., Van Damme, J., Goethals, M., Thomas, G. R., Hoorelbeke, B., Demol, H., Martens, L., Puype, M., Staes, A., and Vandekerckhove, J. (2002) Chromatographic isolation of methionine-containing peptides for gel-free proteome analysis - Identification of more than 800 Escherichia coli proteins. Mol. Cell. Proteomics 1, 896-903
50. Hoofnagle, A. N., Becker, J. O., Oda, M. N., Cavigiolio, G., Mayer, P., and Vaisar, T. (2012) Multiple-reaction monitoring-mass spectrometric assays can accurately measure the relative protein abundance in complex mixtures. Clin. Chem. 58, 777-781
51. Lassman, M. E., McLaughlin, T. M., Somers, E. P., Stefanni, A. C., Chen, Z., Murphy, B. A, Bierilo, K. K., Flattery, A. M., Wong, K. K., Castro-Perez, J. M., Hubbard, B. K., and Roddy, T. P. (2012) A rapid method for cross-species quantitation of apolipoproteins A1, B48 and B100 in plasma by ultra-performance liquid chromatography/tandem mass spectrometry. Rapid Commun. Mass Spectrom. 26, 101-108
52. Percy, A. J., Chambers, A. G., Yang, J., Domanski, D., and Borchers, C. H. (2012) Comparison of standard- and nano-flow liquid chromatography platforms for MRM-based quantitation of putative plasma biomarker proteins. Anal. Bioanal. Chem. DOI 10.1007/s00216-012-6010
53. Trenchevska, O., Kamcheva, E., and Nedelkov, D. (2011) Mass spectrometric immunoassay for quantitative determination of transthyretin and its variants. Proteomics 11, 3633-3641
54. Anderson, N. L., Anderson, N. G., Haines, L. R., Hardie, D. B., Olafson, R. W., and Pearson, T. W. (2004) Mass spectrometric quantitation of peptides and proteins using stable isotope standards and capture by anti-peptide antibodies (SISCAPA). J. Proteome Res. 3, 235-244 (Pubitemid 38500990)
55. Whiteaker, J. R., Zhao, L., Abbatiello, S. E., Burgess, M., Kuhn, E., Lin, C., Pope, M. E., Razavi, M., Anderson, N. L., Pearson, T. W., Carr, S. A., and Paulovich, A. G. (2011) Evaluation of large scale quantitative proteomic assay development using peptide affinity-based mass spectrometry. Mol. Cell. Proteomics 10, M110.005645
56. Beekman, M., Heijmans, B. T., Martin, N. G., Pedersen, N. L., Whitfield, J. B., DeFaire, U., van Baal, G. C. M., Snieder, H., Vogler, G. P., Slagboom, P. E., and Boomsma, D. I. (2002) Heritabilities of apolipoprotein and lipid levels in three countries. Twin Res. 5, 87-97 (Pubitemid 34407936)
57. Riddell, D. R., Zhou, H., Atchison, K., Warwick, H. K., Atkinson, P. J., Jefferson, J., Xu, L., Aschmies, S., Kirksey, Y., Hu, Y., Wagner, E., Parratt, A., Xu, J., Li, Z., Zaleska, M. M., Jacobsen, J. S., Pangalos, M. N., and Reinhart, P. H. (2008) Impact of apolipoprotein E (ApoE) polymorphism on brain ApoE levels. J. Neurosci. 28, 11445-11453
58. Beekman, M., Posthuma, D., Heijmans, B. T., Lakenberg, N., Suchiman, H. E. D., Snieder, H., de Knijff, P., Frants, R. R., van Ommen, G. J. B., Kluft, C., Vogler, G. P., Slagboom, P. E., and Boomsma, D. I. (2004) Combined association and linkage analysis applied to the APOE locus. Genetic Epidemiol. 26, 328-337 (Pubitemid 38580384)
59. Uchida, Y., Ito, S., and Nukina, N. (2000) Sandwich ELISA for the measurement of Apo-E4 levels in serum and the estimation of the allelic status of Apo-E4 isoforms. J. Clin. Lab. Anal. 14, 260-264
60. Bohnet, K., Pillot, T., Visvikis, S., Sabolovic, N., and Siest, G. (1996) Apolipoprotein (apo) E genotype and apoE concentration determine binding of normal very low density lipoproteins to HepG2 cell surface receptors. J. Lipid Res. 37, 1316-1324 (Pubitemid 26239086)
61. Brun, V., Dupuis, A., Adrait, A., Marcellin, M., Thomas, D., Court, M., Vandenesch, F., and Garin, J. (2007) Isotope-labeled protein standards. Mol. Cell. Proteomics 6, 2139-2149
62. Haddy, N., De Bacquer, D., Chemaly, M. M., Maurice, M., Ehnholm, C., Evans, A., Sans, S., Martins, M. D., De Backer, G., Siest, G., and Visvikis, S. (2002) The importance of plasma concentration in addition apolipoprotein E to its common polymorphism on inter-individual variation in lipid levels: results from Apo Europe. Eur. J. Human Gen. 10, 841-850 (Pubitemid 36054566)
63. Schiele, F., De Bacquer, D., Vincent-Viry, M., Beisiegel, U., Ehnholm, C., Evans, A., Kafatos, A., Martins, M. C., Sans, S., Sass, C., Visvikis, S., De Backer, G., and Siest, G. (2000) Apolipoprotein E serum concentration and polymorphism in six European countries: the ApoEurope Project. Atherosclerosis 152, 475-488
64. Artiga, M. J., Bullido, M. J., Sastre, I., Recuero, M., Garcia, M. A., Aldudo, J., Vazquez, J., and Valdivieso, F. (1998) Allelic polymorphisms in the transcriptional regulatory region of apolipoprotein E gene. Febs Letts. 421, 105-108 (Pubitemid 28288072)
65. Bekris, L. M., Millard, S. P., Galloway, N. M., Vuletic, S., Albers, J. J., Lie, G., Galasko, D. R., DeCarli, C., Farlow, M. R., Clark, C. M., Quinn, J. F., Kaye, J. A., Schellenberg, G. D., Tsuang, D., Peskind, E. R., and Yu, C. E. Multiple SN (2008) Ps within and surrounding the apolipoprotein E gene influence cerebrospinal fluid apolipoprotein E protein levels. J. Alzheimers Dis. 13, 255-266 (Pubitemid 352039030)
66. Lambert, J. C., Berr, C., Pasquier, F., Delacourte, A., Frigard, B., Cottel, D., Perez-Tur, J., Mouroux, V., Mohr, M., Cecyre, D., Galasko, D., Lendon, C., Poirier, J., Hardy, J., Mann, D., Amouyel, P., and Chartier-Harlin, M. C. (1998) Pronounced impact of Th1/E47cs mutation compared with -491 AT mutation on neural APOE gene expression and risk of developing Alzheimer's disease. Human Mol. Gen. 7, 1511-1516 (Pubitemid 28429934)
67. Lambert, J. C., Brousseau, T., Defosse, V., Evans, A., Arveiler, D., Ruidavets, J. B., Haas, B., Cambou, J. P., Luc, G., Ducimetiere, P., Cambien, F., Chartier-Harlin, M. C., and Amouyel, P. (2000) Independent association of an APOE gene promoter polymorphism with increased risk of myocardial infarction and decreased APOE plasma concentrations - the ECTIM Study. Human Mol. Gen. 9, 57-61 (Pubitemid 30145288)
68. Laws, S. M., Hone, E., Taddei, K., Harper, C., Dean, B., McClean, C., Masters, C., Lautenschlager, N., Gandy, S. E., and Martins, R. N. (2002) Variation at the APOE-491 promoter locus is associated with altered brain levels of apolipoprotein E. Mol. Psychiatry 7, 886-890
69. Laws, S. M., Taddei, K., Martins, G., Paton, A., Fisher, C., Clarnette, R., Hallmayer, J., Brooks, W. S., Gandy, S. E., and Martins, R. N. (1999) The -491AA polymorphism in the APOE gene is associated with increased plasma apoE levels in Alzheimer's disease. Neuroreport 10, 879-882 (Pubitemid 29393839)
70. Bullido, M. J., Artiga, M. J., Recuero, M., Sastre, I., Garcia, M. A., Aldudo, J., Lendon, C., Han, S. W., Morris, J. C., Frank, A., Vazquez, J., Goate, A., and Valdivieso, F. (1998) A polymorphism in the regulatory region of APOE associated with risk for Alzheimer's dementia. Nat. Gen. 18, 69-71 (Pubitemid 28027883)
71. Parker, G. R., Cathcart, H. M., Huang, R., Lanham, I. S., Corder, E. H., and Poduslo, S. E. (2005) Apolipoprotein gene E4 allele promoter polymorphisms as risk factors for Alzheimer's disease. Psychiatric Gen. 15, 271-275 (Pubitemid 44491465)
72. Ramos, M. C., Matias, S., Artiga, M. J., Pozueta, J., Sastre, I., Valdivieso, F., and Bullido, M. J. (2005) Neuronal specific regulatory elements in apolipoprotein E gene proximal promoter. Neuroreport 16, 1027-1030 (Pubitemid 40904760)
73. Town, T., Paris, D., Fallin, D., Duara, R., Barker, W., Gold, M., Crawford, F., and Mullan, M. (1998) The -491A/T apolipoprotein E promoter polymorphism association with Alzheimer's disease: independent risk and linkage disequilibrium with the known APOE polymorphism. Neurosci. Lett. 252, 95-98 (Pubitemid 28384501)
74. Wang, J. C., Kwon, J. M., Shah, P., Morris, J. C., and Goate, A.: (2000) Effect of APOE genotype and promoter polymorphism on risk of Alzheimer's disease. Neurology 55, 1644-1649
75. Yu, C. E., Seltman, H., Peskind, E. R., Galloway, N., Zhou, P. X., Rosenthal, E., Wijsman, E. M., Tsuang, D. W., Devlin, B., and Schellenberg, G. D. (2007) Comprehensive analysis of APOE and selected proximate markers for late-onset Alzheimer's disease: Patterns of linkage disequilibrium and disease/marker association. Genomics 89, 655-665 (Pubitemid 46719797)
76. Lambert, J. C., and Amouyel, P. (2007) Genetic heterogeneity of Alzheimer's disease: Complexity and advances. Psychoneuroendocrinology 32, S62-S70
77. Lambert, J. C., and Amouyel, P. (2011) Genetics of Alzheimer's disease: new evidences for an old hypothesis? Curr. Opinion Gen. Develop. 21, 295-301
78. Bales, K. R., Liu, F., Wu, S., Lin, S., Koger, D., DeLong, C., Hansen, J. C., Sullivan, P. M., and Paul, S. M. (2009) Human APOE isoform-dependent effects on brain beta-amyloid levels in PDAPP transgenic mice. J. Neurosci. 29, 6771-6779
79. Fryer, J. D., Simmons, K., Parsadanian, M., Bales, K. R., Paul, S. M., Sullivan, P. M., and Holtzman, D. M. (2005) Human apolipoprotein E4 alters the amyloid-beta 40:42 ratio and promotes the formation of cerebral amyloid angiopathy in an amyloid precursor protein transgenic model. J. Neurosci. 25, 2803-2810 (Pubitemid 40389238)
80. Fagan, A. M., Watson, M., Parsadanian, M., Bales, K. R., Paul, S. M., and Holtzman, D. M. (2002) Human and murine ApoE markedly alters A beta metabolism before and after plaque formation in a mouse model of Alzheimer's disease. Neurobiol. Disease 9, 305-318 (Pubitemid 34442079)
81. Holtzman, D. M., Bales, K. R., Tenkova, T., Fagan, A. M., Parsadanian, M., Sartorius, L. J., Mackey, B., Olney, J., McKeel, D., Wozniak, D., and Paul, S. M. (2000) Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer's disease. Proc. Natl. Acad. Sci. U. S. A. 97, 2892-2897 (Pubitemid 30159268)
82. Chiang, G. C., Insel, P. S., Tosun, D., Schuff, N., Truran-Sacrey, D., Raptentsetsang, S. T., Jack, C. R., Jr., Aisen, P. S., Petersen, R. C., and Weiner, M. W. (2010) Hippocampal atrophy rates and CSF biomarkers in elderly APOE2 normal subjects. Neurology 75, 1976-1981
83. Morris, J. C., Roe, C. M., Xiong, C., Fagan, A. M., Goate, A. M., Holtzman, D. M., and Mintun, M. A. (2010) APOE Predicts Amyloid-Beta but Not Tau Alzheimer Pathology in Cognitively Normal Aging. Ann. Neurol. 67, 122-131
84. Reiman, E. M., Chen, K., Liu, X., Bandy, D., Yu, M., Lee, W., Ayutyanont, N., Keppler, J., Reeder, S. A., Langbaum, J. B. S., Alexander, G. E., Klunk, W. E., Mathis, C. A., Price, J. C., Aizenstein, H. J., DeKosky, S. T., and Caselli, R. J. (2009) Fibrillar amyloid-beta burden in cognitively normal people at 3 levels of genetic risk for Alzheimer's disease. Proc. Natl. Acad. Sci. U. S. A. 106, 6820-6825
85. Sunderland, T., Mirza, N., Putnam, K. T., Linker, G., Bhupali, D., Durham, R., Soares, H., Kimmel, L., Friedman, D., Bergeson, J., Csako, G., Levy, J. A., Bartko, J. J., and Cohen, R. M.: (2004) Cerebrospinal fluid beta-amyloid(1-42) and tau in control subjects at risk for Alzheimer's disease: The effect of APOE epsilon 4 allele. Biol. Psychiatry 56, 670-676 (Pubitemid 39446849)
86. Blennow, K., Hesse, C., and Fredman, P. (1994) Cerebrospinal-fluid apolipoprotein-E is reduced in Alzheimers-disease. Neuroreport 5, 2534-2536
87. Carlsson, J., Armstrong, V. W., Reiber, H., Felgenhauer, K., and Seidel, D. (1991) Clinical Relevance of the Quantification of Apolipoprotein-E in Cerebrospinal-Fluid. Clin. Chim. Acta 196, 167-176
88. Fukuyama, R., Mizuno, T., Mori, S., Yanagisawa, K., Nakajima, K., and Fushiki, S. (2000) Age-dependent decline in the apolipoprotein e level in cerebrospinal fluid from control subjects and its increase in cerebrospinal fluid from patients with Alzheimer's disease. Eur. Neurol. 43, 161-169 (Pubitemid 30189538)
89. Hesse, C., Larsson, H., Fredman, P., Minthon, L., Andreason, N., Davidsson, P., and Blennow, K. (2000) Measurement of apolipoprotein E (apoE) in cerebrospinal fluid. Neurochem. Res. 25, 511-517 (Pubitemid 30317684)
90. Kunicki, S., Richardson, J., Mehta, P. D., Kim, K. S., and Zorychta, E. (1998) The effects of age, apolipoprotein E phenotype and gender on the concentration of amyloid-beta (A beta) 40, A beta 42, apolipoprotein E and transthyretin in human cerebrospinal fluid. Clin. Biochem. 31, 409-415 (Pubitemid 28385242)
91. Landen, M., Hesse, C., Fredman, P., Regland, B., Wallin, A., and Blennow, K. (1996) Apolipoprotein E in cerebrospinal fluid from patients with Alzheimer's disease and other forms of dementia is reduced but without any correlation to the apoE4 isoform. Dementia 7, 273-278 (Pubitemid 26278688)
92. Lefranc, D., Vermersch, P., Dallongeville, J., DaemsMonpeurt, C., Petit, H., and Delacourte, A. (1996) Relevance of the quantification of apolipoprotein E in the cerebrospinal fluid in Alzheimer's disease. Neurosci. Letts. 212, 91-94 (Pubitemid 26298548)
93. Rosler, N., Wichart, I., Bancher, C., and Jellinger, K. A. (1996) Tau protein and apolipoprotein E in CSF diagnostics of Alzheimer's disease: Impact on non-Alzheimer's dementia? J. Neural Trans. Supplement 49, 259-266 (Pubitemid 26275604)
94. Skoog, I., Hesser, C., Fredman, P., Andreasson, L. A., Palmertz, B., and Blennow, K. (1997) Apolipoprotein E in cerebrospinal fluid in 85-year-old subjects - Relation to dementia, apolipoprotein E polymorphism, cerebral atrophy, and white matter lesions. Arch. Neurol. 54, 267-272
95. Song, H., Saito, K., Seishima, M., Noma, A., Urakami, K., and Nakashima, K. (1997) Cerebrospinal fluid apo E and apo A-I concentrations in early and late-onset Alzheimer's disease. Neurosci. Letts. 231, 175-178 (Pubitemid 27381942)
96. Cramer, P. E., Cirrito, J. R., Wesson, D. W., Lee, C. Y. D., Karlo, J. C., Zinn, A. E., Casali, B. T., Restivo, J. L., Goebel, W. D., James, M. J., Brunden, K. R., Wilson, D. A., and Landreth, G. E. (2012) ApoE-Directed Therapeutics Rapidly Clear beta-Amyloid and Reverse Deficits in AD Mouse Models. Science 335, 1503-1506